Product image of Enerzair Breezhaler (Mometasone Furoate, Glycopyrronium Bromide, Indacaterol) supplied by GNH India

Enerzair Breezhaler

Active Ingredient:
Mometasone Furoate, Glycopyrronium Bromide, Indacaterol
Origin:
EU

Enerzair Breezhaler (Mometasone Furoate, Glycopyrronium Bromide, Indacaterol)

Enerzair Breezhaler combines Mometasone Furoate, Glycopyrronium Bromide, and Indacaterol for inhalation use. This medication is designed to manage respiratory conditions by reducing inflammation and improving airflow. Ideal for those seeking comprehensive respiratory support.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Enerzair Breezhaler is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. The combination of Mometasone Furoate, Glycopyrronium Bromide, and Indacaterol works to reduce inflammation in the airways, making it easier to breathe. This medication is often prescribed for individuals who require both a corticosteroid and a bronchodilator to manage their symptoms effectively.

Side Effects

  • Common effects of Enerzair Breezhaler may include improved breathing and reduced wheezing. Some users might experience mild side effects such as throat irritation or a dry mouth. It is important to use this medication as directed by a healthcare professional to minimize potential side effects.

Precautions & Warnings

  • Enerzair Breezhaler should be used with caution in individuals with certain medical conditions, such as heart disease or glaucoma. It is important to follow the prescribed dosage and administration instructions carefully. Always consult a healthcare professional before starting any new medication.

Avoid Interactions

  • Enerzair Breezhaler may interact with other medications, including beta-blockers and certain antifungal drugs. It is important to inform your healthcare provider about all the medications you are currently taking to avoid potential interactions. Additionally, avoid using this medication with alcohol unless advised by a healthcare professional.

Frequently Asked Questions

Enerzair Breezhaler is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma.

Enerzair Breezhaler is an inhalation medication. Follow the instructions provided by your healthcare professional for proper use.

Common side effects may include throat irritation, dry mouth, and mild respiratory discomfort.

It is important to consult your healthcare provider before using Enerzair Breezhaler with other medications to avoid potential interactions.

Enerzair Breezhaler should be used with caution in individuals with certain medical conditions. Always consult a healthcare professional before starting this medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate, Glycopyrronium Bromide, Indacaterol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT